Skip to main content
. 2025 May 31;17(11):1861. doi: 10.3390/cancers17111861
AYA Adolescents and young adults
BS Bone sarcoma
CR Conversion rate
CPP Cancer Patient Pathway
CT Chemotherapy
DFS Dermatofibrosarcoma
DFS Disease-free survival
DM Distant metastasis
DMFS Distant metastasis-free survival
DMR Distant metastasis rate
DR Detection rate
DSS Disease-specific survival
EP Emergency presentation
FDS Faster diagnostic standard
FSG French Sarcoma Group
GIST Gastrointestinal stromal tumor
GP General practitioner
HG High grade
H/N Head/neck
KS Kaposi’s sarcoma
LG Low grade
LMS Leiomyosarcoma
LRFS Local recurrence-free survival
m Months
MDT Multidisciplinary team
MRI Magnetic resonance imaging
NPRs Non-planned resections
MFS Metastasis-free survival
NCDB National Cancer Database
NICE National Institute for Care and Care Excellence
OpS Orthopedic surgeon
OS Overall survival
Path Pathology
PPV Positive predictive value
RT Radiotherapy
RTD Route to diagnosis
RPS Retroperitoneal sarcoma
Rx Radiology
SC Subcutaneous
SDTM Sarcoma diagnostic triage meeting
SSMN Scottish Sarcoma Managed Clinical Network
S/SD Size/symptom duration ratio
SS Synovial sarcoma
STS Soft tissue sarcoma
SUK20S Sarcoma UK 2020 survey
T0 Patient’s delay
T1 General practitioner’s delay
T2 Non-specialist’s delay
TTI Time to treatment initiation
T/Extr Trunk/extremities
2WW Two Weeks Wait
WD_LPS Well-differentiated liposarcoma
w Week
w/o Without